These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 16834825)
1. Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief. Schley M; Legler A; Skopp G; Schmelz M; Konrad C; Rukwied R Curr Med Res Opin; 2006 Jul; 22(7):1269-76. PubMed ID: 16834825 [TBL] [Abstract][Full Text] [Related]
2. Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study. de Vries M; van Rijckevorsel DCM; Vissers KCP; Wilder-Smith OHG; van Goor H; Clin Gastroenterol Hepatol; 2017 Jul; 15(7):1079-1086.e4. PubMed ID: 27720917 [TBL] [Abstract][Full Text] [Related]
3. The Effect of a Novel form of Extended-Release Gabapentin on Pain and Sleep in Fibromyalgia Subjects: An Open-Label Pilot Study. North JM; Hong KS; Rauck RL Pain Pract; 2016 Jul; 16(6):720-9. PubMed ID: 26059271 [TBL] [Abstract][Full Text] [Related]
4. Open-label, add-on study of tetrahydrocannabinol for chronic nonmalignant pain. Haroutiunian S; Rosen G; Shouval R; Davidson E J Pain Palliat Care Pharmacother; 2008; 22(3):213-7. PubMed ID: 19042851 [TBL] [Abstract][Full Text] [Related]
5. [The therapeutic use of D9-tetrahydrocannabinol (dronabinol) in refractory neuropathic pain]. Clermont-Gnamien S; Atlani S; Attal N; Le Mercier F; Guirimand F; Brasseur L Presse Med; 2002 Nov; 31(39 Pt 1):1840-5. PubMed ID: 12496714 [TBL] [Abstract][Full Text] [Related]
6. Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey. Weber J; Schley M; Casutt M; Gerber H; Schuepfer G; Rukwied R; Schleinzer W; Ueberall M; Konrad C Anesthesiol Res Pract; 2009; 2009():. PubMed ID: 20798872 [TBL] [Abstract][Full Text] [Related]
7. Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis. Conte A; Bettolo CM; Onesti E; Frasca V; Iacovelli E; Gilio F; Giacomelli E; Gabriele M; Aragona M; Tomassini V; Pantano P; Pozzilli C; Inghilleri M Eur J Pain; 2009 May; 13(5):472-7. PubMed ID: 18603457 [TBL] [Abstract][Full Text] [Related]
8. The effects of intradermal fentanyl and ketamine on capsaicin-induced secondary hyperalgesia and flare reaction. Koppert W; Zeck S; Blunk JA; Schmelz M; Likar R; Sittl R Anesth Analg; 1999 Dec; 89(6):1521-7. PubMed ID: 10589641 [TBL] [Abstract][Full Text] [Related]
9. Effect of cannabidiolic acid and ∆ Rock EM; Limebeer CL; Parker LA Psychopharmacology (Berl); 2018 Nov; 235(11):3259-3271. PubMed ID: 30225659 [TBL] [Abstract][Full Text] [Related]
10. An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. Johnson JR; Lossignol D; Burnell-Nugent M; Fallon MT J Pain Symptom Manage; 2013 Aug; 46(2):207-18. PubMed ID: 23141881 [TBL] [Abstract][Full Text] [Related]
11. In an exploratory randomized, double-blind, placebo-controlled, cross-over study, psychoactive doses of intravenous delta-9-tetrahydrocannabinol fail to produce antinociceptive effects in healthy human volunteers. Schindler EAD; Schnakenberg Martin AM; Sewell RA; Ranganathan M; DeForest A; Pittman BP; Perrino A; D'Souza DC Psychopharmacology (Berl); 2020 Oct; 237(10):3097-3107. PubMed ID: 32632491 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of pregabalin as a monotherapy versus combined pregabalin and milnacipran in the management of fibromyalgia. Abdel Fattah YH; Elnemr R Int J Rheum Dis; 2020 Nov; 23(11):1474-1480. PubMed ID: 32886447 [TBL] [Abstract][Full Text] [Related]
13. [Tetrahydrocannabinol (THC) in patients with fibromyalgia syndrome (FMS) : A retrospective study of changes in pain, psychometric variables, and analgesic consumption during inpatient interdisciplinary multimodal pain therapy (IMPT)]. Bettstetter H; Schäfer A Schmerz; 2024 Aug; 38(4):259-266. PubMed ID: 37289246 [TBL] [Abstract][Full Text] [Related]
14. [Tetrahydrocannabinol for treatment of chronic pain]. Elsner F; Radbruch L; Sabatowski R Schmerz; 2001 Jun; 15(3):200-4. PubMed ID: 11810357 [TBL] [Abstract][Full Text] [Related]
15. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids. Janoyan JJ; Crim JL; Darmani NA Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine. Bennett R; Russell IJ; Choy E; Spaeth M; Mease P; Kajdasz D; Walker D; Wang F; Chappell A Clin Ther; 2012 Apr; 34(4):824-37. PubMed ID: 22421576 [TBL] [Abstract][Full Text] [Related]
17. Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability. de Vries M; Van Rijckevorsel DC; Vissers KC; Wilder-Smith OH; Van Goor H Br J Clin Pharmacol; 2016 Mar; 81(3):525-37. PubMed ID: 26505163 [TBL] [Abstract][Full Text] [Related]
18. The therapeutic use of cannabinoids: Forensic aspects. Indorato F; Liberto A; Ledda C; Romano G; Barbera N Forensic Sci Int; 2016 Aug; 265():200-3. PubMed ID: 27038587 [TBL] [Abstract][Full Text] [Related]
19. Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide. Houser SJ; Eads M; Embrey JP; Welch SP Brain Res; 2000 Feb; 857(1-2):337-42. PubMed ID: 10700588 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy. Narang S; Gibson D; Wasan AD; Ross EL; Michna E; Nedeljkovic SS; Jamison RN J Pain; 2008 Mar; 9(3):254-64. PubMed ID: 18088560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]